CaÑeda, Ruben A.

HRN: 27-25-79  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/06/2025
06/13/2025
IV
1g
Q6h
ATP
Remove - Pending Acceptance
06/06/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
06/06/2025
06/13/2025
IV
5mL
QID
T/C Oral Candidiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: